BlackRock’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181M | Sell |
4,148,260
-134,643
| -3% | -$5.88M | ﹤0.01% | 1669 |
|
|
2025
Q1 | $117M | Sell |
4,282,903
-73,400
| -2% | -$2.01M | ﹤0.01% | 1880 |
|
|
2024
Q4 | $175M | Buy |
4,356,303
+144,654
| +3% | +$5.82M | ﹤0.01% | 1731 |
|
|
2024
Q3 | $199M | Buy |
4,211,649
+56,220
| +1% | +$2.66M | ﹤0.01% | 1651 |
|
|
2024
Q2 | $124M | Buy |
4,155,429
+499,769
| +14% | +$14.9M | ﹤0.01% | 1891 |
|
|
2024
Q1 | $147M | Buy |
3,655,660
+89,049
| +2% | +$3.58M | ﹤0.01% | 1819 |
|
|
2023
Q4 | $90.8M | Buy |
3,566,611
+208,727
| +6% | +$5.31M | ﹤0.01% | 2103 |
|
|
2023
Q3 | $46.7M | Buy |
3,357,884
+132,038
| +4% | +$1.84M | ﹤0.01% | 2400 |
|
|
2023
Q2 | $74.2M | Sell |
3,225,846
-104,344
| -3% | -$2.4M | ﹤0.01% | 2215 |
|
|
2023
Q1 | $98.7M | Sell |
3,330,190
-4,711
| -0.1% | -$140K | ﹤0.01% | 2007 |
|
|
2022
Q4 | $83.2M | Buy |
3,334,901
+130,219
| +4% | +$3.25M | ﹤0.01% | 2105 |
|
|
2022
Q3 | $69.8M | Buy |
3,204,682
+376,248
| +13% | +$8.19M | ﹤0.01% | 2185 |
|
|
2022
Q2 | $55.7M | Sell |
2,828,434
-590,650
| -17% | -$11.6M | ﹤0.01% | 2382 |
|
|
2022
Q1 | $145M | Buy |
3,419,084
+21,544
| +0.6% | +$912K | ﹤0.01% | 1869 |
|
|
2021
Q4 | $216M | Buy |
3,397,540
+357,109
| +12% | +$22.7M | 0.01% | 1677 |
|
|
2021
Q3 | $179M | Buy |
3,040,431
+591,914
| +24% | +$34.8M | 0.01% | 1788 |
|
|
2021
Q2 | $119M | Buy |
2,448,517
+934,594
| +62% | +$45.3M | ﹤0.01% | 2136 |
|
|
2021
Q1 | $58.8M | Buy |
1,513,923
+97,292
| +7% | +$3.78M | ﹤0.01% | 2483 |
|
|
2020
Q4 | $87.8M | Buy |
1,416,631
+650,037
| +85% | +$40.3M | ﹤0.01% | 2125 |
|
|
2020
Q3 | $24.8M | Buy |
+766,594
| New | +$24.8M | ﹤0.01% | 2676 |
|